| ACTINIUM PHARMACEUTICALS INC. |
| USA |
| Gesundheit |
| US00507W2061 / A2QA48 |
| 7AY1 (Frankfurt) |
| FRA:7AY1, ETR:7AY1, 7AY1:GR |
| - |
| https://www.actiniumpharm.. |
|
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted radiotherapies for cancer. Its current pipeline centers on antibody radiation conjugates and actinium-225-based programs designed to deliver r..
>Volltext.. |
| 27.89 Mio. EUR |
| -2.9 Mio. EUR |
| 30.22 Mio. EUR |
| 9.15 Mio. EUR |
| 9.74 Mio. EUR |
| 0.31 EUR |
| 1.15 Mio. EUR |
| 31.41 Mio. EUR |
| -19.52 Mio. EUR |
| 3.94 |
| - |
| - |
| - |
| - |
| - |
| - |
| ACTINIUM |
| 09.09.26 |
|